Literature DB >> 11478865

NMR structure and backbone dynamics of a concatemer of epidermal growth factor homology modules of the human low-density lipoprotein receptor.

N D Kurniawan1, K Aliabadizadeh, I M Brereton, P A Kroon, R Smith.   

Abstract

The ligand-binding region of the low-density lipoprotein (LDL) receptor is formed by seven N-terminal, imperfect, cysteine-rich (LB) modules. This segment is followed by an epidermal growth factor precursor homology domain with two N-terminal, tandem, EGF-like modules that are thought to participate in LDL binding and recycling of the endocytosed receptor to the cell surface. EGF-A and the concatemer, EGF-AB, of these modules were expressed in Escherichia coli. Correct protein folding of EGF-A and the concatemer EGF-AB was achieved in the presence or absence of calcium ions, in contrast to the LB modules, which require them for correct folding. Homonuclear and heteronuclear 1H-15N NMR spectroscopy at 17.6 T was used to determine the three-dimensional structure of the concatemer. Both modules are formed by two pairs of short, anti-parallel beta-strands. In the concatemer, these modules have a fixed relative orientation, stabilized by calcium ion-binding and hydrophobic interactions at the interface. 15N longitudinal and transverse relaxation rates, and [1H]-15N heteronuclear NOEs were used to derive a model-free description of the backbone dynamics of the molecule. The concatemer appears relatively rigid, particularly near the calcium ion-binding site at the module interface, with an average generalized order parameter of 0.85+/-0.11. Some mutations causing familial hypercholesterolemia may now be rationalized. Mutations of D41, D43 and E44 in the EGF-B calcium ion-binding region may affect the stability of the linker and thus the orientation of the tandem modules. The diminutive core also provides little structural stabilization, necessitating the presence of disulfide bonds. The structure and dynamics of EGF-AB contrast with the N-terminal LB modules, which require calcium ions both for folding to form the correct disulfide connectivities and for maintenance of the folded structure, and are connected by highly mobile linking peptides. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11478865     DOI: 10.1006/jmbi.2001.4867

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  8 in total

1.  Role of an intramolecular contact on lipoprotein uptake by the LDL receptor.

Authors:  Zhenze Zhao; Peter Michaely
Journal:  Biochim Biophys Acta       Date:  2011-04-09

Review 2.  Endoplasmic reticulum quality control in lipoprotein metabolism.

Authors:  Cari M Koerner; Benjamin S Roberts; Saskia B Neher
Journal:  Mol Cell Endocrinol       Date:  2019-08-20       Impact factor: 4.102

3.  Calcium as a crucial cofactor for low density lipoprotein receptor folding in the endoplasmic reticulum.

Authors:  Florentina Pena; Annemieke Jansens; Guus van Zadelhoff; Ineke Braakman
Journal:  J Biol Chem       Date:  2010-01-20       Impact factor: 5.157

Review 4.  Thyroglobulin From Molecular and Cellular Biology to Clinical Endocrinology.

Authors:  Bruno Di Jeso; Peter Arvan
Journal:  Endocr Rev       Date:  2015-11-23       Impact factor: 19.871

5.  Molecular basis for LDL receptor recognition by PCSK9.

Authors:  Hyock Joo Kwon; Thomas A Lagace; Markey C McNutt; Jay D Horton; Johann Deisenhofer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

6.  Intradomain Confinement of Disulfides in the Folding of Two Consecutive Modules of the LDL Receptor.

Authors:  Juan Martínez-Oliván; Hugo Fraga; Xabier Arias-Moreno; Salvador Ventura; Javier Sancho
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

7.  Ca2+ binding to complement-type repeat domains 5 and 6 from the low-density lipoprotein receptor-related protein.

Authors:  Olav M Andersen; Henrik Vorum; Bent Honoré; Hans C Thøgersen
Journal:  BMC Biochem       Date:  2003-08-18       Impact factor: 4.059

Review 8.  Proprotein convertase subtilisin/kexin type 9: from the discovery to the development of new therapies for cardiovascular diseases.

Authors:  Nicola Ferri
Journal:  Scientifica (Cairo)       Date:  2012-09-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.